The Nonpeptide Growth Hormone Secretagogue, MK‐0677, Activates Hypothalamic Arcuate Nucleus Neurons in vivo
- 1 February 1998
- journal article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 10 (2) , 111-118
- https://doi.org/10.1046/j.1365-2826.1998.00176.x
Abstract
There is accumulating evidence that the hypothalamic arcuate nucleus plays an important role in mediating the effects of growth hormone secretagogues on growth hormone (GH) release from the anterior pituitary gland. One such nonpeptidyl secretagogue, MK-0677, has been shown to directly stimulate growth hormone release from isolated pituitary cells but its central actions remain to be established. Therefore, in the present study, we have employed both immunocytochemical and in vivo electrophysiological techniques to examine the effects of MK-0677 within the hypothalamic arcuate nucleus of the male rat. In conscious male rats, both central and systemic injection of MK-0677 induced fos-like immunoreactivity specifically within the arcuate nucleus indicating selective neuronal activation of neurons within this region. MK-0677 induced-activation was generally confined close to the wall of the third ventricle, whereas systemic injection of the peptide secretagogue, GHRP-6, also induced fos-like immunoreactivity in more lateral regions of the nucleus. In urethane anaesthetized rats, intravenous injection of MK-0677 increased the electrical activity of a population of antidromically identified (i.e. neuroendocrine) arcuate neurons with a similar electrophysiological profile to cells excited by GHRP-6. The activity of neuroendocrine arcuate neurons excited by MK-0677 injection could be attenuated by a subsequent systemic injection of somatostatin. However, the activity of neuroendocrine arcuate neurons unaffected by MK-0677 injection and the activity of non-neuroendocrine arcuate neurons was unaltered by somatostatin injection. Taken together, the immunocytochemical and electrophysiological results suggest that systemic and central administration of MK-0677 activates a population of neurons in the arcuate nucleus. Furthermore, the inhibitory effects of somatostatin on MK-0677-induced excitation of these neuroendocrine cells is consistent with an action of neurons involved in the regulation of GH release.Keywords
This publication has 26 references indexed in Scilit:
- Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissuesMolecular Brain Research, 1997
- Induction of c-fos Messenger Ribonucleic Acid in Neuropeptide Y and Growth Hormone (GH)-Releasing Factor Neurons in the Rat Arcuate Nucleus Following Systemic Injection of the GH Secretagogue, GH-Releasing Peptide-6*Endocrinology, 1997
- Attenuation of the Growth Hormone Secretagogue Induction of Fos Protein in the Rat Arcuate Nucleus by Central Somatostatin ActionNeuroendocrinology, 1997
- Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.Proceedings of the National Academy of Sciences, 1995
- Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neuronsNeuroscience, 1993
- Patterns of Growth Hormone-Eeleasing Factor and Somatostatin Secretion into the Hypophysial-Portal Circulation of the RatScience, 1985
- On thein Vitroandin VivoActivity of a New Synthetic Hexapeptide that Acts on the Pituitary to Specifically Release Growth Hormone*Endocrinology, 1984
- Localization of GRF-like immunoreactive neurons in the rat brainPeptides, 1983
- Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused AcromegalyScience, 1982
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973